NanoViricides, Inc.
NNVC
$1.26
$0.010.80%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 47.77% | 118.57% | 58.41% | 12.87% | -7.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.75% | 55.93% | -34.95% | 5.40% | 19.13% |
| Operating Income | 5.75% | -55.93% | 34.95% | -5.40% | -19.13% |
| Income Before Tax | 4.13% | -58.83% | 34.01% | -8.91% | -21.19% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.13% | -58.83% | 34.01% | -8.91% | -21.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.13% | -58.83% | 34.01% | -8.91% | -21.19% |
| EBIT | 5.75% | -55.93% | 34.95% | -5.40% | -19.13% |
| EBITDA | 6.63% | -61.31% | 36.89% | -5.92% | -21.15% |
| EPS Basic | 22.77% | -35.71% | 37.09% | -7.59% | -19.83% |
| Normalized Basic EPS | 22.67% | -35.71% | 37.08% | -7.54% | -19.81% |
| EPS Diluted | 22.77% | -35.71% | 37.09% | -7.59% | -19.83% |
| Normalized Diluted EPS | 22.67% | -35.71% | 37.08% | -7.54% | -19.81% |
| Average Basic Shares Outstanding | 24.06% | 17.04% | 4.92% | 1.23% | 1.17% |
| Average Diluted Shares Outstanding | 24.06% | 17.04% | 4.92% | 1.23% | 1.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |